针对阿坎萨摩巴角膜炎的新型有效医学疗法
Antonio Di Zazzo1, Chiara De Gregorio, Marco Coassin
1Ophthalmology Complex Operative Unit, University Campus Bio-Medico, Rome, Italy.
Eye & contact lens
|May 6, 2024
概括
一种新型的0.08%聚胺 (PHMB) 方案为阿坎萨摩巴角膜炎提供了有前途的治疗方法,显著减少了疾病持续时间和复发风险. 这种方法在早期临床使用中改善了患者的治疗结果和生活质量.
科学领域:
- 眼科医生 眼科 眼科
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 阿坎萨摩巴角膜炎 (Acanthamoeba keratitis,简称AK) 是一种严重的微生物角膜炎.
- 对AK的标准治疗可以延长时间,并且可能具有有限的疗效.
- 需要新的治疗策略来改善AK患者的治疗结果.
研究的目的:
- 报告一种新药治疗阿坎萨摩巴角膜炎的首次临床使用情况.
- 为了评估标准化方案的有效性和安全性,使用Polyhexanide (PHMB) 0.08%用于AK.
主要方法:
- 一个干预观察病例系列,涉及两名AK患者.
- 患者最初接受标准治疗 (PHMB 0.02%和普罗巴米丁 0.1%),没有成功.
- 然后,根据一项新的标准化方案,患者接受PHMB0.08%的治疗,随访时间至少为7个月.
主要成果:
- 在这两种情况下,PHMB 0.08%眼滴在新方案中导致角膜病变在4周内完全愈合.
- 角膜不透明性和新血管化的缓慢但稳定的改善.
- 最好的视力度逐渐改善,在随访期间没有观察到感染的复发.
结论:
- 使用PHMB0.08%的新型标准化方案显示在治疗阿坎萨摩巴角膜炎方面有希望的反应.
- 这种治疗大大减少了疾病的持续时间和复发的可能性.
- 这种方法显著改善了患者的生活质量.
更多相关视频
06:10Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
Published on: December 8, 2023
1.6K
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
9.2K
相关概念视频
01:28Angle Closure Glaucoma: Treatment
480
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
480
01:27Open Angle Glaucoma: Treatment
432
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
432